MACCIONI, ELIAS
 Distribuzione geografica
Continente #
EU - Europa 298.688
NA - Nord America 8.942
AS - Asia 1.504
AF - Africa 17
Continente sconosciuto - Info sul continente non disponibili 8
SA - Sud America 8
OC - Oceania 3
Totale 309.170
Nazione #
IT - Italia 295.966
US - Stati Uniti d'America 8.876
CN - Cina 1.029
UA - Ucraina 944
SE - Svezia 741
DE - Germania 360
SG - Singapore 289
FI - Finlandia 256
GB - Regno Unito 217
FR - Francia 70
CA - Canada 55
VN - Vietnam 53
IN - India 45
RU - Federazione Russa 31
HK - Hong Kong 24
BE - Belgio 20
NL - Olanda 18
PK - Pakistan 18
KR - Corea 17
IE - Irlanda 13
IR - Iran 13
AT - Austria 12
CZ - Repubblica Ceca 9
EU - Europa 7
PT - Portogallo 7
EG - Egitto 6
MX - Messico 6
ES - Italia 5
RO - Romania 5
CL - Cile 4
ID - Indonesia 4
CR - Costa Rica 3
MA - Marocco 3
MU - Mauritius 3
TN - Tunisia 3
TR - Turchia 3
AU - Australia 2
CH - Svizzera 2
HR - Croazia 2
JP - Giappone 2
LT - Lituania 2
MD - Moldavia 2
PL - Polonia 2
A1 - Anonimo 1
BO - Bolivia 1
CM - Camerun 1
CO - Colombia 1
DO - Repubblica Dominicana 1
EC - Ecuador 1
HU - Ungheria 1
IL - Israele 1
IM - Isola di Man 1
IQ - Iraq 1
IS - Islanda 1
KW - Kuwait 1
LA - Repubblica Popolare Democratica del Laos 1
NZ - Nuova Zelanda 1
PA - Panama 1
PE - Perù 1
PH - Filippine 1
SA - Arabia Saudita 1
SK - Slovacchia (Repubblica Slovacca) 1
TW - Taiwan 1
ZA - Sudafrica 1
Totale 309.170
Città #
Cagliari 290.217
Uta 5.157
Fairfield 990
Chandler 875
Woodbridge 848
Houston 641
Ashburn 544
Ann Arbor 531
Nyköping 529
Boardman 492
Jacksonville 491
Wilmington 410
Seattle 396
Dearborn 378
Cambridge 303
Nanjing 169
Singapore 160
New York 157
Beijing 147
Shanghai 140
Santa Clara 138
Boston 122
Helsinki 122
Redwood City 64
Shenyang 58
Nanchang 54
Dong Ket 53
San Diego 50
Guangzhou 47
Hebei 41
Jiaxing 41
Toronto 41
Changsha 39
Sassari 38
Los Angeles 35
Milan 34
Jinan 32
Mountain View 29
Verona 28
Kunming 26
Herndon 24
London 24
Norwalk 24
Tianjin 23
Brussels 20
Hong Kong 19
Auburn Hills 18
Zhengzhou 18
Orange 17
Seoul 17
Taizhou 17
Atlanta 16
Hangzhou 16
Washington 16
Hefei 15
Rome 15
Ningbo 14
Phoenix 14
Pune 13
Wuhan 13
Amsterdam 11
Falls Church 11
Vienna 10
Mumbai 9
Munich 9
Redmond 9
Dublin 8
Olbia 8
Quartu Sant'elena 8
Saint Petersburg 8
Selargius 8
Brno 7
Gujranwala 7
Indiana 7
Quartu Sant'Elena 7
Ottawa 6
Paris 6
San Francisco 6
Walnut 6
Zerfalìu 6
Borås 5
Chicago 5
Frankfurt am Main 5
Islamabad 5
Montreal 5
Nürnberg 5
Siracusa 5
Yellow Springs 5
Baotou 4
Central 4
Cosenza 4
Fuzhou 4
Millbury 4
Napoli 4
Wuxi 4
Bultei 3
Cairo 3
Chengdu 3
Jakarta 3
Kilburn 3
Totale 305.260
Nome #
(3Z)-3-(2-[4-(aryl)-1,3-thiazol-2-yl]hydrazin-1-ylidene)-2,3-dihydro- 1H -indol-2-one derivatives as dual inhibitors of HIV-1 reverse transcriptase 14.614
Exploring the thiazole scaffold for the identification of new agents for the treatment of fluconazole resistant Candida 4.935
Methoxyflavones from Stachys glutinosa with binding affinity to opioid receptors: in silico, in vitro, and in vivo studies 4.600
Phenylpropenoids from Bupleurum fruticosum as Anti-Human Rhinovirus Species A Selective Capsid Binders 4.569
Natural product-inspired esters and amides of ferulic and caffeic acid as dual inhibitors of HIV-1 reverse transcriptase 4.561
Design, synthesis, and biological evaluation of 1,3-diarylpropenones as dual inhibitors of HIV-1 reverse transcriptase 4.384
Isatin: a privileged scaffold for the design of carbonic anhydrase inhibitors 4.336
Quercetin blocks Ebola Virus infection by counteracting the VP24 Interferon inhibitory function 4.298
2-(2-cycloalkylidene hydrazin-1-yl)-4-aryl-1,3-thiazoles: a promising class of antifungal agents 4.287
Lactoferrin- and antitransferrin-modified liposomes for brain targeting of the NK3 receptor agonist senktide: Preparation and in vivo evaluation 4.285
Ribonuclease H/DNA polymerase HIV-1 reverse transcriptase dual inhibitor: mechanistic studies on the allosteric mode of action of isatin-based compound RMNC6 4.230
3-Acetyl-2,5-diaryl-2,3-dihydro-1,3,4-oxadiazoles: A new scaffold for the selective inhibition of monoamine oxidase B 4.200
Isatin thiazoline hybrids as dual inhibitors of HIV-1 reverse transcriptase 4.066
N-Alkyl dien- and trienamides from the roots of Otanthus maritimus with binding affinity for opioid and cannabinoid receptors 3.853
New 4-[(3-cyclohexyl-4-aryl-2,3-dihydro-1,3-thiazol-2-ylidene)amino]benzene-1-sulfonamides, synthesis and inhibitory activity toward carbonic anhydrase I, II, IX, XII 3.825
Drug design, synthesis, in vitro and in silico evaluation of selective monoaminoxidase B inhibitors based on 3-acetyl-2-dichlorophenyl-5-aryl-2,3-dihydro-1,3,4-oxadiazole chemical scaffold 3.678
A novel series of 3,4-disubstituted dihydropyrazoles: Synthesis and evaluation for MAO enzyme inhibition 3.655
Identification of Myricetin as Ebolavirus VP35-dsRNA interaction inhibitor through a novel fluorescence-based assay 3.620
Ferulic Acid Esters and Withanolides: in Search of Withania somnifera GABAA Receptor Modulators 3.470
Targeting tumor associated carbonic anhydrase IX and XII: Highly isozyme selective coumarin and psoralen inhibitors 3.442
Identification of HIV-1 reverse transcriptase dual inhibitors by a combined shape-, 2D-fingerprint- and pharmacophore-based virtual screening approach 3.364
Sennoside A, derived from the traditional chinese medicine plant Rheum L., is a new dual HIV-1 inhibitor effective on HIV-1 replication 3.334
N-alkylamides from Otanthus maritimus: structure elucidation, binding affinity for cannabinoid receptors and computational study 3.299
Through scaffold modification to 3,5-diaryl-4,5-dihydroisoxazoles: new potent and selective inhibitors of monoamine oxidase B 3.268
Coumarins from Magydaris pastinacea as inhibitors of the tumour-associated carbonic anhydrases IX and XII: isolation, biological studies and in silico evaluation 3.254
Molecular Aspects of the RT/drug Interactions. Perspective of Dual Inhibitors 3.218
Multi-target activity of Hemidesmus indicus decoction against innovative HIV-1 drug targets and characterization of Lupeol mode of action 3.214
Studies on Cycloheptathiophene-3-carboxamide Derivatives as Allosteric HIV-1 Ribonuclease H Inhibitors 3.201
Synthesis and biological assessment of novel 2-thiazolylhydrazones and computational analysis of their recognition by monoamine oxidase B 3.163
Synthesis of new 3-aryl-4,5-dihydropyrazole-1-carbothioamide derivatives. An investigation on their ability to inhibit monoamine oxidase 3.131
N-Acylbenzenesulfonamide dihydro-1,3,4-oxadiazole hybrids: seeking selectivity toward carbonic anhydrase isoforms 3.089
Biochemical characterization of a multi-drug resistant HIV-1 subtype AG reverse transcriptase: antagonism of AZT discrimination and excision pathways and sensitivity to RNase H inhibitors 3.014
Novel natural non-nucleoside inhibitors of HIV-1 reverse transcriptase identified by shape- and structure-based virtual screening techniques 2.985
Design, Synthesis and Biological Evaluation of New 1,3-Diarylpropenones as Dual Inhibitors of HIV-1 RT. 2.944
Tuning the Dual Inhibition of Carbonic Anhydrase and Cyclooxygenase by Dihydrothiazole Benzensulfonamides 2.917
Investigating the Anticancer Activity of Isatin/Dihydropyrazole Hybrids 2.908
Site directed mutagenesis studies on HIV-1 reverse transcriptase (RT) enlighten the mechanism of action of a new Ribonuclease H/DNA polymerase RT dual inhibitor 2.861
Site directed mutagenesis studies on HIV-1 reverse transcriptase (RT) shed light on the mechanism of action of a new Ribonuclease H/ DNA polymerase RT dual inhibitor 2.815
Design, Synthesis and Biological Evaluation of New 1,3-Diarylpropenones as Single Site Dual Inhibitors of HIV-1 RT 2.798
From cycloheptathiophene-3-carboxamide to oxazinone-based derivatives as allosteric HIV-1 ribonuclease H inhibitors 2.758
MD protocol validation for the study of MAOB-inhibitor complexes 2.679
Mutagenic study on HIV-1 reverse transcriptase to explore the mechanism of action of HIV-1 reverse transcriptase dual inhibitors 2.671
In search of new antitumor agents through the combination of individually active moieties: construction of a [3,5-diaryl-(4,5- dihydropyrazol-1-yl)-4-oxo-1,3-thiazol-5-ylidene]- 1H-indol-2-ones library 2.648
Chromenone derivatives as a versatile scaffold with dual mode of inhibition of HIV-1 reverse transcriptase-associated Ribonuclease H function and integrase activity 2.627
Synthesis and biological activity evaluation of new dual-inhibitors of both associated functions of HIV-1 RT 2.539
Structure-based virtual screening of novel natural alkaloid derivatives as potential binders of h-telo and c-myc DNA G-quadruplex conformations 2.530
Towards the total block of HIV-1 Reverse Transcriptase: the dual-inhibitors approach 2.524
3-[2-(4-aryl-1,3-thiazol-2-yl)hydrazin-1-ylidene]-1H-indol-2-ones as new potential dual inhibitors of polimerase and ribonuclease HIV-1 RT associated function 2.521
Synthesis and characterization of new phthalhydrazothiazole derivatives: A preliminary investigation on their activity against hepatocellular carcinoma 2.444
Investigation on the mechanism of action of new dual inhibitors of HIV-1 RT 2.441
Exploring new structural features of the 4-[(3-methyl-4-aryl-2,3-dihydro-1,3-thiazol-2-ylidene)amino]benzenesulphonamide scaffold for the inhibition of human carbonic anhydrases 2.434
Meeting report: Fourth Summer School on Innovative Approaches for Identification of Antiviral Agents (IAAASS) 2.353
Chalcones as novel dual inhibitors of HIV-1 reverse transcriptase 2.349
New dual inhibitors of RT associated functions: investigation on their mechanism and mode of action 2.348
New promising scaffolds for the inhibition of monoamine oxidase B 2.209
Hit Identification of a Novel Dual Binder for h-telo/c-myc G-Quadruplex by a Combination of Pharmacophore Structure-Based Virtual Screening and Docking Refinement 2.206
Exploring new scaffolds for the inibition of the Ribonuclease H function of RT HIV-1 2.170
Terapia delle infezioni sostenute da Candida spp.: nuovi approcci mediante derivati isotiosemicarbazonici. 2.081
Meeting report: Third Summer School on innovative approaches for identification of antiviral agents (IAAASS) 2.042
Isatin derivatives as new scaffolds for HIV-1 reverse transcriptase associated RNase H and RDDP dual inhibitors 2.033
Design, synthesis and biolgical activity evaluation of new HIV-1 reverse transcriptase dual inhibitors 1.986
In vitro activity of 2-cyclohexylidenhydrazo-4-phenil-thiazole compared with those of amphotericin b and fluconazole against clinical isolates of Candida spp. and fluconazole-resistant Candida albicans 1.986
Design, synthesis and biological activity evaluation of c-myc proto-oncogene binders as potential antitumor agents 1.951
null 1.949
Identification of HIV-1 reverse transcriptase dual inhibitors by a combined shape-, 2D-fingerprint- and pharmacophore-based virtual screening approach 1.945
Design, synthesis and biological activity evaluation of new HIV-1 reverse transcriptase dual inhibitors 1.875
Identification of HIV-1 reverse trascriptase dual inhibitors by a combined shape-, 2D fingerprint and pharmacophore-based virtual screening approch 1.856
New reactions of carbon suboxide with alkines 1.853
Synthesis and anti-microbial activity evaluation of some new 1-benzoyl-isothiosemicarbazides. 1.849
Semipreparative HPLC enantioseparation, chiroptical properties, and absolute configuration of two novel cyclooxygenase-2 inhibitors 1.807
Design of new inhibitors of the HIV-1 Reverse Transcriptase associated Ribonuclease H function: a synthetic approach 1.795
Synthesis, semipreparative HPLC separation, biological evaluation, and 3D-QSAR of hydrazothiazole derivatives as human monoamine oxidase B inhibitors 1.794
Brain delivery of the NK3 receptor agonist senktide by immunoliposome: an in vivo microdialysis study 1.731
Identification of new scaffolds for the inhibition of HIV-1 Reverse Transcriptase associated Ribonuclease H function by means of shape based similarity screening 1.718
Application of an immobilised amylose-based chiral stationary phase to the development of new monoamine oxidase B inhibitors 1.699
SITE DIRECT MUTAGENESIS AND KINETIC STUDIES TO EXPLORE THE MECHANISM OF ACTION OF ISATIN DERIVATIVES AS HIV-1 REVERSE TRANSCRIPTASE DUAL INHIBITORS 1.688
Exploring new scaffolds for the inhibition of the Ribonuclease H function of RT HIV-1 1.620
Synthesis and anti-microbial activity of isothiosemicarbazones and cyclic analogues 1.601
SYNTHESIS, MOLECULAR MODELLING, INHIBITORY ACTIVITY, AND SELECTIVITY TOWARDS MONOAMINE OXIDASE OF NEW HETEROCYCLIC SCAFFOLDS 1.596
New Dihydrothiazole Benzensulfonamides: Looking for Selectivity toward Carbonic Anhydrase Isoforms I, II, IX, and XII 1.596
Synthesis and antimicrobial activity of novel arylidenisothiosemicarbazones 1.570
Semicarbazide-sensitive amine oxidase/vascular adhesion protein-1: a patent survey 1.551
Synthesis and biological evaluation of new dual inhibitors of HIV-1 associated functions 1.530
null 1.499
Effetti sulla attività di AmB nei confronti di biofilm di C. albicans in seguito ad esposizione a EM01D2 e fluconazolo. 1.498
Flavonoids and Acid-Hydrolysis derivatives of Neo-Clerodane diterpenes from Teucrium flavum subsp. glaucum as inhibitors of the HIV-1 reverse transcriptase–associated RNase H function 1.486
From classic to innovative approaches in HIV-1 infection treatment 1.471
null 1.415
null 1.406
Derivati ciclici isotiosemicarbazonici come approccio alternativo nella terapia delle infezioni sostenute da Candida spp. 1.368
Shape based computer aided similarity screening: a valid tool in the discovery of new scaffolds for the inhibition of HIV-1 reverse transcriptase associated ribonuclease H function 1.329
Identification of G-quadruplex DNA/RNA binders: Structure-based virtual screening and biophysical characterization 1.249
The preparation of non ionic surfactant vesicles formed from hexacyclophosphazenic derivatives 1.205
9-fluorenones as new scaffolds for G-quadruplex DNA 1.156
Synthesis of new arylidencycloalkylpyrazoles of potential biological interest 1.098
A combined shape-, 2D-fingerprint-and pharmacophore-based virtual screening for the identification of dual inhibitors targeting HIV-1 reverse transcriptase. 1.068
An investigation of the biological effect of structural modifications of isothiosemicarbazones and their cyclic analogues 1.040
Design, synthesis and biological evaluation of new fluorenone derivatives as DNA G-quadruplex binders 1.039
Synthesis, molecular modelling, inhibitory acivity, and selectivity towards monoamine oxidase of new heterocyclic scaffold 1.035
Exploring new scaffolds for the dual inhibition of HIV-1 RT polymerase and ribonuclease associated functions 1.029
Totale 264.229
Categoria #
all - tutte 353.299
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 353.299


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202026.748 0 0 0 0 0 11.725 6.379 1.440 1.197 1.643 1.621 2.743
2020/202172.922 2.647 2.691 3.944 17.633 13.665 8.290 6.218 4.614 1.996 4.479 4.401 2.344
2021/202214.008 1.700 1.214 707 981 1.186 930 870 734 1.327 1.365 1.419 1.575
2022/202323.332 2.103 3.454 2.892 2.226 1.572 2.521 1.290 1.647 1.248 1.333 1.869 1.177
2023/202422.577 1.096 695 2.080 1.828 2.344 3.929 2.885 1.628 1.203 1.336 1.657 1.896
2024/202544.888 15.268 14.318 6.700 4.383 2.091 2.128 0 0 0 0 0 0
Totale 309.669